Product
Dose-4 Group
Aliases
dose-4 group
1 clinical trial
1 indication
Indication
Gout ArthritisClinical trial
A Randomized, Open-label,Single Dosing Clinical Trail to Investigate the Pharmacokinetic/Pharmacodynamic Characteristics of IBI128 in Chinese Healthy SubjectsStatus: Completed, Estimated PCD: 2024-03-16